Literature DB >> 33175881

Inhibition of transforming growth factor-β signaling in myeloid cells ameliorates aortic aneurysmal formation in Marfan syndrome.

Hironori Hara1, Sonoko Maemura1, Takayuki Fujiwara1, Norifumi Takeda1, Satoshi Ishii1, Hiroki Yagi1, Takaaki Suzuki1, Mutsuo Harada1, Haruhiro Toko1,2, Tsubasa Kanaya1, Hideaki Ijichi3, Harold L Moses4, Eiki Takimoto1, Hiroyuki Morita1, Hiroshi Akazawa1, Issei Komuro1.   

Abstract

Increased transforming growth factor-β (TGF-β) signaling contributes to the pathophysiology of aortic aneurysm in Marfan syndrome (MFS). Recent reports indicate that a small but significant number of inflammatory cells are infiltrated into the aortic media and adventitia in MFS. However, little is known about the contribution of myeloid cells to aortic aneurysmal formation. In this study, we ablated the TGF-β type II receptor gene Tgfbr2 in myeloid cells of Fbn1C1039G/+ MFS mice (Fbn1C1039G/+;LysM-Cre/+;Tgfbr2fl/fl mice, hereinafter called Fbn1C1039G/+;Tgfbr2MyeKO) and evaluated macrophage infiltration and TGF-β signaling in the aorta. Aneurysmal formation with fragmentation and disarray of medial elastic fibers observed in MFS mice was significantly ameliorated in Fbn1C1039G/+;Tgfbr2MyeKO mice. In the aorta of Fbn1C1039G/+;Tgfbr2MyeKO mice, both canonical and noncanonical TGF-β signals were attenuated and the number of infiltrated F4/80-positive macrophages was significantly reduced. In vitro, TGF-β enhanced the migration capacity of RAW264.7 macrophages. These findings suggest that TGF-β signaling in myeloid cells promotes aortic aneurysmal formation and its inhibition might be a novel therapeutic target in MFS.

Entities:  

Year:  2020        PMID: 33175881      PMCID: PMC7657512          DOI: 10.1371/journal.pone.0239908

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

MFS is a systemic disorder of connective tissues caused by pathogenic variants in the FBN1 gene, which encodes the major component of the extracellular matrix microfibril fibrillin-1 [1]. Fibrillin-1 binds to the latent complex of TGF-β and regulates its activity in response to pathophysiological stresses. FBN1 pathogenic variants that affect the structure or function of fibrillin-1 protein not only cause structural weakness of the connective tissue but also stimulate improper latent TGF-β activation [2, 3]. Among the diverse manifestations of MFS, aortic aneurysm and dissection are the most serious and the leading causes of death [4]. The aortic TGF-β signaling is activated in MFS, and treatment of adult MFS mice with a TGF-β neutralizing antibody (TGF-NAb) prevents aortic root dilatation associated with attenuation of the canonical Smad and the noncanonical extracellular signal-regulated kinase (ERK) signaling pathways [5]. On the contrary, early initiation of TGF-NAb treatment from postnatal day 16 (P16) in fibrillin-1 hypomorphic (Fbn1) mice exacerbates aneurysmal formation, but the initiation from P45 ameliorates it [6]. Adult mice with a conditional tamoxifen-inducible biallelic disruption of Tgfbr2 in smooth muscle cells (Myh11-CreER;Tgfbr2) develop aortic aneurysm [7]. These findings suggest that TGF-β signaling plays pivotal roles both in early postnatal aortic development and adult aortic homeostasis. Recent studies show that a small but significant number of inflammatory cells are infiltrated into the aortic media and adventitia [8, 9]. Importantly, the number of inflammatory cells infiltrated into the aorta was larger in patients who required prophylactic repair of the aorta early in life, compared to patients who did not need prophylactic repair until elderly [8]. It is possible that inflammatory cells play a crucial role in aortic aneurysmal formation. Here, we hypothesized that upregulated TGF-β activity in myeloid cells plays an important role in the disease progression. In the present study, we ablated the Tgfbr2 gene in myeloid cells of Fbn1 MFS mice and evaluated the effect on aortic aneurysmal formation in MFS.

Methods

Animals

Generation of homozygous Tgfbr2-floxed (Tgfbr2) mice and genotyping have been previously described [10]. Fbn1 and LysM-Cre/+ mice were obtained from the Jackson Laboratory [11, 12]. All animal experiments were approved by the University of Tokyo Ethics Committee for Animal Experiments and strictly adhered to the guidelines of the University of Tokyo for animal experiments. Mice were monitored daily by animal facility staff and observed for signs of stress and distress.

Efficacy of Cre-mediated recombination in Tgfbr2 mice

To confirm the previously reported high-efficacy of Cre-mediated recombination in Tgfbr2 mice [13], macrophages were obtained from the peritoneal cavity of 6-week-old mice 4 days after injection of 4% thioglycollate (211260; Becton Dickinson and Company). Total RNA isolation, cDNA conversion, and semi-quantitative reverse transcription polymerase chain reaction (PCR) were performed as previously reported [14, 15]. The PCR primers used were as follows (forward and reverse, respectively): Tgfbr2, 5’-GCAAGTTTTGCGATGTGAGA-3’ and 5’-GGCATCTTCCAGAGTGAAGC-3’; 18S rRNA, 5’-CGGCTACCACATCCAAGGAA-3’, and 5’-AGCTGGAATTACCGCGGC-3’.

Noninvasive blood pressure measurement and ultrasonography

Systolic blood pressure was measured using a tail-cuff method (MK-2000ST; Muromachi Kikai). Ultrasonography was performed using the Vevo 2100 Imaging System (VisualSonics) while mice were anesthetized with 2.5% isoflurane. The luminal diameters of the aortic root were measured at the age of 8, 12, and 30 weeks by B-mode imaging.

Macroscopic images and histological analysis

Before excision of aorta, mice were euthanized by isoflurane overexposure. Following intra-cardiac perfusion of 4% paraformaldehyde, thoracic aorta was cleared of surrounding tissue and digitally captured using Leica MZ10 F microscope and Leica DFC450 C camera. Tissue sections (5 μm) were prepared at the proximal ascending aorta (just above sinotubular junction). Elastica van Gieson staining was used to visualize the aortic elastic fiber structure. Elastic fiber breaks were defined as the presence of discernable breaks of continuous elastin fiber and counted circumferentially in all laminae [16, 17]. Rat anti-mouse monoclonal F4/80 antibody (MCA497; Bio-Rad) was used for immunohistochemical staining to recognize macrophages at the dilution of 1:200. The VECTASTAIN Elite ABC system (PK-6104; Vector Laboratories) was used for sensitive avidin/biotin-based peroxidase system and hematoxylin was used for counterstain of nuclei. The number of infiltrated macrophages was determined by counting cells at 40× magnification from four random fields, and the average number per area of aortic adventitia was used as an individual value [18, 19]. Rabbit-anti-mouse monoclonal phospho-Smad2/3 antibody (#3108; Cell Signaling Technology) was used as a primary antibody at the dilution of 1:100. The signal was visualized by ImmPRESS Reagent (MP-7401; Vector Laboratories) and TSA Fluorescein (SAT701B001EA; Perkin Elmer). DAPI (D523; Wako) was used for nuclei staining prior to mounting with VECTASHIELD (H-1000; Vector Laboratories). The ratio of positively stained nuclei to the total number of nuclei in the aorta was determined at 20× magnification from three random fields, and the average percentage was used as an individual value [20, 21]. Rabbit-anti-mouse polyclonal phospho-ERK1/2 antibody (#9101; Cell Signaling Technology) was used as a primary antibody at the dilution of 1:200. The signal was visualized by ImmPRESS Reagent (MP-7401; Vector Laboratories). 3, 3'-Diaminobenzidine tetrahydrochloride (SK-4100; Vector Laboratories) was used as substrate for horseradish peroxidase. The ratio of positively stained area to the total area of the aorta was determined at 40× magnification from three random fields, and the average percentage was used as an individual value [22]. Digital images of tissue sections were obtained using Olympus BX 51 microscope and Olympus DP 70 camera. Brightness and contrast were adjusted linearly across the entirety of each image.

MTS cell proliferation assay

RAW264.7 cells under fetal calf serum-free starved condition were incubated with the vehicle or 5 ng/mL of recombinant human TGF-β1 (209–16544; Wako) for 24 hours. Then, the cell proliferation rate was evaluated using a CellTiter 96® AQueous One Solution Cell Proliferation Assay kit (G3582; Promega) and a microplate-reading luminometer (Wallac Arvo Mx 1420; PerkinElmer) [23].

In vitro cell migration assay

RAW264.7 cells were grown to confluence before the cell monolayer was scratched using a sterile P200 micropipette tip [24]. Next, cells were washed with phosphate-buffered saline, cultured at 37°C in fetal calf serum-free DMEM and treated with the vehicle or 5 ng/mL of recombinant human TGF-β1 (Wako) for 24 hours. The images of the scratched area were captured immediately after the scratch and after 24 hours to monitor cell migration. The migration capacity was quantified from the area between the edges of cells in the scratch zone.

Statistical analysis

All analyses were performed using JMP Pro 14.2.0 (SAS Institute). Data are shown as mean ± standard deviation. The assumption of homogeneity of variance was tested using Levene’s test. The significance of differences among means was evaluated using Student’s t-test, Welch’s t-test, one-way analysis of variance followed by post hoc Tukey–Kramer test, or Kruskal–Wallis test followed by post hoc Steel–Dwass test. P-values < 0.05 were considered statistically significant.

Results

To examine the impact of TGF-β signaling in myeloid cells on aortic aneurysmal formation in MFS, we ablated Tgfbr2 in myeloid cells in Fbn1 heterozygous MFS mice by crossing with myeloid-specific Tgfbr2 knockout mice (Tgfbr2 mice). Exon 2 of Tgfbr2 (169 bp) was flanked with loxP sites and Cre-mediated recombination produced out-of-frame transcripts in myeloid cells of Tgfbr2 mice (S1 Fig) [10, 13]. Compared to control wild-type mice (Tgfbr2) and MFS mice (Fbn1;Tgfbr2), myeloid-specific Tgfbr2 disruption did not affect systolic blood pressure or body weight of Tgfbr2 and Fbn1;Tgfbr2 mice (S2 Fig). Fbn1;Tgfbr2 MFS mice developed progressive aortic root dilatation to 30 weeks of age without early death. On the other hand, aneurysmal formation was significantly suppressed in both male and female Fbn1;Tgfbr2 mice, and Tgfbr2 mice did not develop any aortic phenotypes (Fig 1). Histological analysis revealed aberrant thickening of the aortic media with fragmentation and disarray of elastic fibers in Fbn1;Tgfbr2 mice, but they were markedly reduced in Fbn1;Tgfbr2 mice (Fig 2). These findings suggest that TGF-β signaling in myeloid cells is inessential in normal aortic development and homeostasis but it promotes the progression of aortic aneurysmal formation in MFS.
Fig 1

Myeloid-specific ablation of Tgfbr2 ameliorated aortic aneurysm in Fbn1 mice.

(A, B) Representative macroscopic appearance (A) and ultrasound images (B) of the thoracic aorta at 30 weeks of age in Tgfbr2 , Tgfbr2, Fbn1;Tgfbr2 , and Fbn1 ;Tgfbr2 mice. Scale bar, 1 mm. Arrows indicate aortic root (AoR); AAo, Ascending aorta. (C) Aortic root diameter measured by ultrasonography at 8, 12, and 30 weeks of age. n = 3–12 per group. Data are shown as mean ± standard deviation. *p < 0.05, **p < 0.01, ***p < 0.001.

Fig 2

Myeloid-specific ablation of Tgfbr2 reduced aortic medial thickening and elastic fiber fragmentation in Fbn1 mice.

(A) Representative images of Elastica van Gieson staining of the proximal ascending aorta at 30 weeks of age in Tgfbr2 , Tgfbr2, Fbn1;Tgfbr2 , and Fbn1 ;Tgfbr2 mice. Scale bar, 100 μm. (B) Average number of elastic fiber breaks per section. All mice were male. n = 4–7 per group. Data are shown as mean ± standard deviation. *p < 0.05, **p < 0.01, ***p < 0.001.

Myeloid-specific ablation of Tgfbr2 ameliorated aortic aneurysm in Fbn1 mice.

(A, B) Representative macroscopic appearance (A) and ultrasound images (B) of the thoracic aorta at 30 weeks of age in Tgfbr2 , Tgfbr2, Fbn1;Tgfbr2 , and Fbn1 ;Tgfbr2 mice. Scale bar, 1 mm. Arrows indicate aortic root (AoR); AAo, Ascending aorta. (C) Aortic root diameter measured by ultrasonography at 8, 12, and 30 weeks of age. n = 3–12 per group. Data are shown as mean ± standard deviation. *p < 0.05, **p < 0.01, ***p < 0.001.

Myeloid-specific ablation of Tgfbr2 reduced aortic medial thickening and elastic fiber fragmentation in Fbn1 mice.

(A) Representative images of Elastica van Gieson staining of the proximal ascending aorta at 30 weeks of age in Tgfbr2 , Tgfbr2, Fbn1;Tgfbr2 , and Fbn1 ;Tgfbr2 mice. Scale bar, 100 μm. (B) Average number of elastic fiber breaks per section. All mice were male. n = 4–7 per group. Data are shown as mean ± standard deviation. *p < 0.05, **p < 0.01, ***p < 0.001. Next, we evaluated macrophage infiltration into the aneurysmal wall, as macrophage is reported to be a major component of infiltrating inflammatory cells [8]. F4/80-positive macrophages were significantly increased mainly in the adventitia of the proximal ascending aorta (just above sinotubular junction) of Fbn1;Tgfbr2 mice at 30 weeks of age. However, the number of macrophages infiltrated into the aorta of Fbn1;Tgfbr2 mice was significantly reduced compared to Fbn1;Tgfbr2 mice (Fig 3).
Fig 3

Myeloid-specific ablation of Tgfbr2 reduced macrophage infiltration into the aortic wall in Fbn1 mice.

(A) Representative images of F4/80 (marker of macrophage, red arrowheads) of the proximal ascending aorta at 30 weeks of age in Tgfbr2 , Tgfbr2, Fbn1;Tgfbr2 , and Fbn1 ;Tgfbr2 mice. Cell nuclei were counterstained with hematoxylin. All mice were male. Scale bar, 50 μm (20 μm in inset). (B) Average number of F4/80-positive macrophages per area of aortic adventitia. Four random 40× magnification fields were investigated. All mice were male. n = 4–7 per group. Data are shown as mean ± standard deviation. *p < 0.05, ***p < 0.001.

Myeloid-specific ablation of Tgfbr2 reduced macrophage infiltration into the aortic wall in Fbn1 mice.

(A) Representative images of F4/80 (marker of macrophage, red arrowheads) of the proximal ascending aorta at 30 weeks of age in Tgfbr2 , Tgfbr2, Fbn1;Tgfbr2 , and Fbn1 ;Tgfbr2 mice. Cell nuclei were counterstained with hematoxylin. All mice were male. Scale bar, 50 μm (20 μm in inset). (B) Average number of F4/80-positive macrophages per area of aortic adventitia. Four random 40× magnification fields were investigated. All mice were male. n = 4–7 per group. Data are shown as mean ± standard deviation. *p < 0.05, ***p < 0.001. We further examined the effect of myeloid-specific Tgfbr2 disruption on TGF-β signaling-related pathways in the aortic wall. Increased Smad2/3 and ERK1/2 phosphorylations were evident in the ascending aorta of Fbn1;Tgfbr2 mice, but they were remarkably attenuated in Fbn1;Tgfbr2 mice (Fig 4).
Fig 4

Myeloid-specific ablation of Tgfbr2 attenuated phospho-Smad2/3 and phospho-ERK1/2 signals in Fbn1 mice.

(A, B) Representative phospho-Smad2/3 (A) and phospho-ERK1/2 (B) staining of the proximal ascending aorta at 30 weeks of age in Tgfbr2 , Tgfbr2, Fbn1;Tgfbr2 , and Fbn1 ;Tgfbr2 mice. Scale bar, 50 μm. Arrowheads show the representative positive staining. (C) Average percentage of positive staining of phospho-Smad2/3 per nuclei. Three random 20× magnification fields were investigated. All mice were male. n = 4–7 per group. Data are shown as mean ± standard deviation. *p < 0.05, **p < 0.01. (D) Average percentage of positive stained area of phospho-ERK1/2 per aortic area. Three random 40× magnification fields were investigated. All mice were male. n = 4–7 per group. Data are shown as mean ± standard deviation. *p < 0.05, **p < 0.01, ***p < 0.001.

Myeloid-specific ablation of Tgfbr2 attenuated phospho-Smad2/3 and phospho-ERK1/2 signals in Fbn1 mice.

(A, B) Representative phospho-Smad2/3 (A) and phospho-ERK1/2 (B) staining of the proximal ascending aorta at 30 weeks of age in Tgfbr2 , Tgfbr2, Fbn1;Tgfbr2 , and Fbn1 ;Tgfbr2 mice. Scale bar, 50 μm. Arrowheads show the representative positive staining. (C) Average percentage of positive staining of phospho-Smad2/3 per nuclei. Three random 20× magnification fields were investigated. All mice were male. n = 4–7 per group. Data are shown as mean ± standard deviation. *p < 0.05, **p < 0.01. (D) Average percentage of positive stained area of phospho-ERK1/2 per aortic area. Three random 40× magnification fields were investigated. All mice were male. n = 4–7 per group. Data are shown as mean ± standard deviation. *p < 0.05, **p < 0.01, ***p < 0.001. Finally, we investigated the effect of TGF-β on the migration capacity of macrophage using an in vitro monolayer wound healing assay. After RAW264.7 cells, a murine macrophage cell line, reached confluence, an artificial gap was created in the macrophage monolayer using a straight line. TGF-β treatment (5 ng/mL) did not promote cell proliferation (Fig 5A) but significantly enhanced the wound closure rate 24 hours after scratching (Fig 5B and 5C). These data indicates that TGF-β could upregulate the migration capacity of RAW264.7 macrophages.
Fig 5

Effects of TGF-β treatment on the proliferation and migration capacity of RAW264.7 macrophages.

(A) MTS cell proliferation assay. n = 6 per group. Data are shown as mean ± standard deviation. n.s, not significant. (B, C) In vitro cell migration assay. A monolayer of RAW264.7 cells was scratched with a P200 pipette tip, which induced migration of cells into the denuded area to close the wound in the presence or absence of TGF-β (5 ng/mL) for 24 hours. (B) Representative images obtained immediately after the scratch and after 24 hours. (C) The migration capacity was quantified from the area between the edges of cells in the scratch zone. n = 10 per group. Data are shown as mean ± standard deviation. ***p < 0.001.

Effects of TGF-β treatment on the proliferation and migration capacity of RAW264.7 macrophages.

(A) MTS cell proliferation assay. n = 6 per group. Data are shown as mean ± standard deviation. n.s, not significant. (B, C) In vitro cell migration assay. A monolayer of RAW264.7 cells was scratched with a P200 pipette tip, which induced migration of cells into the denuded area to close the wound in the presence or absence of TGF-β (5 ng/mL) for 24 hours. (B) Representative images obtained immediately after the scratch and after 24 hours. (C) The migration capacity was quantified from the area between the edges of cells in the scratch zone. n = 10 per group. Data are shown as mean ± standard deviation. ***p < 0.001.

Discussion

In this study, we examined whether TGF-β signaling in myeloid cells plays a crucial role in aortic aneurysmal formation. Myeloid-specific Tgfbr2 gene ablation in MFS mice attenuated activation of TGF-β signaling and macrophage infiltration in the aorta. In Fbn1 ;Tgfbr2 mice, aortic dilatation was already evident at 8 and 12 weeks of age, but it became less prominent as they grew up (Fig 1C). Therefore, myeloid-specific deletion of Tgfbr2 in MFS model mice ameliorated aortic aneurysmal formation, but it did not prevent the initiation of aortic aneurysmal formation. In addition, TGF-β enhanced the migration capacity of RAW264.7 macrophages in vitro. These findings suggest that TGF-β signaling in myeloid cells might promote the progression of aortic aneurysmal formation, and its inhibition might be a novel therapeutic target in MFS. Tgfbr2 mice, lacking myeloid-specific TGF-β receptor II, but with normal hematopoiesis, have been used to investigate disease-specific roles of TGF-β signaling in myeloid cells [25-28]. In the present study, Tgfbr2 disruption in myeloid cells attenuated phosphorylations of Smad2/3 and ERK1/2 in the ascending aorta of MFS mice (Fig 4). In MFS, mutated FBN1 gene causes reduced or abnormal fibrillin-1 protein, which normally regulates TGF-β bioavailability by releasing latent TGF-β from the extracellular matrix in response to pathophysiological stimuli. Thus, the ensuing upregulation of TGF-β signaling cascades play crucial roles in MFS [3]. Angiotensin II type I blocker losartan has been reported to remarkably ameliorate activation of Smad2 and aortic aneurysmal formation in Fbn1 mice [29], but the mechanism is still not fully understood. It has also been demonstrated that the activation of ERK1/2 as the noncanonical pathway of TGF-β signaling serves as a prominent driver of aortic aneurysmal formation and ERK1/2 signal is inhibited by systemic TGF-β-neutralizing antibody treatment in Fbn1 mice [5]. Furthermore, selective inhibition of ERK1/2 activation ameliorated aortic growth in Fbn1 mice, whereas Smad2 signal was unchanged [5]. These data suggest that TGF-β-driven ERK1/2 activation strongly contributes to aneurysmal formation in MFS, and thus further investigation is needed to elucidate the role of TGF-β signaling in myeloid cells in the ERK1/2 phosphorylation in the aortic wall. It has been reported that pre-treatment of TGF-β exerts biphasic effect on the migration capacity of RAW264.7 cells [30]. However, in the present study, continuous stimulation of TGF-β for 24 hours enhanced the migration capacity of RAW264.7 macrophages (Fig 5). We also demonstrated that Tgfbr2 disruption in myeloid cells reduced macrophage infiltration into the aortic wall (Fig 3). One possible reason for amelioration of aortic aneurysmal formation by myeloid-specific disruption of Tgfbr2 in MFS is the inhibitory effect on macrophage migration and invasion into the diseased aortic wall. Myeloid-specific deletion of Tgfbr2 is reported to reduce migration and invasion capacity of macrophages in tumor-bearing mice as well [26]. Myeloid-specific deletion of Tgfbr2 might alter the expression of adhesion molecules and cytokines and modulate migration capacity. Co-culture of FBN1-knocked-down vascular smooth muscle cells and macrophages derived from Tgfbr2 mice could partially recapitulate the in vivo context of MFS. It has been shown that IL-6 recruits CCR2-positive monocytes which serve to amplify the inflammatory cascade, and IL-6 signaling contributes to Angiotensin II-induced aortic aneurysm [31]. Activation of IL-6 signaling has been demonstrated in hypomorphic Fbn1 mice [32]. Additionally, in the aorta of MFS and familial thoracic aortic aneurysm and dissection, the expression of adhesion molecules surrounding the vasa vasorum in the adventitia is increased [8]. Taken together, reduction of macrophage invasion into the diseased aortic wall might suppress IL-6 signaling and adhesion molecules in the aneurysmal wall of Fbn1;Tgfbr2 mice. This hypothesis should be confirmed in the near future. TGF-β signaling has been shown to play an important role in phenotypic differentiation of macrophage in various pathological situations [33, 34]. Hematopoietic-specific Tgfbr2 deletion has been reported to suppress the expression of Galectin-3, which regulates M2 macrophage polarization, in bone marrow-derived macrophage/monocytes [33]. TGF-β inhibits M1 polarization and promotes M2 polarization in human THP-1 macrophage [34]. Although, to the best of our knowledge, the polarization of macrophage in MFS has not been evaluated, we speculate that phenotypic alteration of macrophage as well as change in the migration capacity due to increased TGF-β signaling may contribute to the progression of aortic aneurysm in MFS. Further investigation of M1/M2 phenotypic alteration and migration capacity of bone marrow-derived macrophage/monocytes from Fbn1;Tgfbr2 mice is needed to elucidate the mechanism. This study demonstrated for the first time that TGF-β signaling disruption in myeloid cells ameliorated Fbn1 MFS aortopathy, where F4/80-positive macrophage infiltration and both canonical and noncanonical TGF-β signals were markedly reduced. Our findings suggest that inhibition of TGF-β signaling in myeloid cells might be a novel therapeutic target in MFS.

The ARRIVE guidelines checklist.

(PDF) Click here for additional data file.

Efficacy of Cre-mediated loxP recombination in myeloid cells.

Semi-quantitative PCR of cDNA prepared from peritoneal macrophages was performed. PCR products for Tgfbr2 and 18s are 197 bp and 188 bp. (TIF) Click here for additional data file.

Effects of Tgfbr2 deletion in myeloid cells on blood pressure and body weight.

Systolic blood pressure (A) and body weight (B) at 30 weeks of age in Tgfbr2 , Tgfbr2, Fbn1;Tgfbr2 , and Fbn1 ;Tgfbr2 mice. n = 4–12 per group. Data are shown as mean ± standard deviation. n.s, not significant. (TIF) Click here for additional data file.

Original image of gel (for S1 Fig).

Products amplified by semi-quantitative reverse transcription polymerase chain reaction using Tgfbr2 and 18s primers were separated by 1.2% agarose gel electrophoresis. (PDF) Click here for additional data file.
  34 in total

1.  Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis.

Authors:  Wei Li; Qingle Li; Yang Jiao; Lingfeng Qin; Rahmat Ali; Jing Zhou; Jacopo Ferruzzi; Richard W Kim; Arnar Geirsson; Harry C Dietz; Stefan Offermanns; Jay D Humphrey; George Tellides
Journal:  J Clin Invest       Date:  2014-01-09       Impact factor: 14.808

2.  TGF-β signaling in myeloid cells is required for tumor metastasis.

Authors:  Yanli Pang; Sudheer Kumar Gara; Bhagelu R Achyut; Zhaoyang Li; Hannah H Yan; Chi-Ping Day; Jonathan M Weiss; Giorgio Trinchieri; John C Morris; Li Yang
Journal:  Cancer Discov       Date:  2013-05-09       Impact factor: 39.397

3.  IL (Interleukin)-33 Suppresses Abdominal Aortic Aneurysm by Enhancing Regulatory T-Cell Expansion and Activity.

Authors:  Jingyong Li; Ni Xia; Shuang Wen; Dan Li; Yuzhi Lu; Muyang Gu; Tingting Tang; Jiao Jiao; Bingjie Lv; Shaofang Nie; Mengyang Liao; Yuhua Liao; Xiangping Yang; Yu Hu; Guo-Ping Shi; Xiang Cheng
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-03       Impact factor: 8.311

4.  Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.

Authors:  Jennifer P Habashi; Daniel P Judge; Tammy M Holm; Ronald D Cohn; Bart L Loeys; Timothy K Cooper; Loretha Myers; Erin C Klein; Guosheng Liu; Carla Calvi; Megan Podowski; Enid R Neptune; Marc K Halushka; Djahida Bedja; Kathleen Gabrielson; Daniel B Rifkin; Luca Carta; Francesco Ramirez; David L Huso; Harry C Dietz
Journal:  Science       Date:  2006-04-07       Impact factor: 47.728

5.  Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome.

Authors:  Daniel P Judge; Nancy J Biery; Douglas R Keene; Jessica Geubtner; Loretha Myers; David L Huso; Lynn Y Sakai; Harry C Dietz
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

6.  TGFβ signaling plays a critical role in promoting alternative macrophage activation.

Authors:  Dapeng Gong; Wei Shi; Sun-ju Yi; Hui Chen; John Groffen; Nora Heisterkamp
Journal:  BMC Immunol       Date:  2012-06-15       Impact factor: 3.615

7.  IL-6 regulates extracellular matrix remodeling associated with aortic dilation in a fibrillin-1 hypomorphic mgR/mgR mouse model of severe Marfan syndrome.

Authors:  Xiaoxi Ju; Talha Ijaz; Hong Sun; Wanda Lejeune; Gracie Vargas; Tuya Shilagard; Adrian Recinos; Dianna M Milewicz; Allan R Brasier; Ronald G Tilton
Journal:  J Am Heart Assoc       Date:  2014-01-21       Impact factor: 5.501

8.  Anatomically specific reactive oxygen species production participates in Marfan syndrome aneurysm formation.

Authors:  Fabian Emrich; Kiril Penov; Mamoru Arakawa; Nathan Dhablania; Grayson Burdon; Albert J Pedroza; Tiffany K Koyano; Young M Kim; Uwe Raaz; Andrew J Connolly; Cristiana Iosef; Michael P Fischbein
Journal:  J Cell Mol Med       Date:  2019-08-11       Impact factor: 5.310

9.  Attenuation of Myeloid-Specific TGFβ Signaling Induces Inflammatory Cerebrovascular Disease and Stroke.

Authors:  M Christine Hollander; Lawrence L Latour; Dan Yang; Hiroki Ishii; Zhiguang Xiao; Yongfen Min; Abhik Ray-Choudhury; Jeeva Munasinghe; Anand S Merchant; P Charles Lin; John Hallenbeck; Manfred Boehm; Li Yang
Journal:  Circ Res       Date:  2017-10-19       Impact factor: 17.367

10.  Discovery of a Small Molecule to Increase Cardiomyocytes and Protect the Heart After Ischemic Injury.

Authors:  Hironori Hara; Norifumi Takeda; Masaki Kondo; Mio Kubota; Tatsuo Saito; Junichi Maruyama; Takayuki Fujiwara; Sonoko Maemura; Masamichi Ito; Atsuhiko T Naito; Mutsuo Harada; Haruhiro Toko; Seitaro Nomura; Hidetoshi Kumagai; Yuichi Ikeda; Hiroo Ueno; Eiki Takimoto; Hiroshi Akazawa; Hiroyuki Morita; Hiroyuki Aburatani; Yutaka Hata; Masanobu Uchiyama; Issei Komuro
Journal:  JACC Basic Transl Sci       Date:  2018-11-12
View more
  1 in total

Review 1.  The Predictive Role of Plasma Biomarkers in the Evolution of Aortopathies Associated with Congenital Heart Malformations.

Authors:  Amalia Făgărășan; Maria Oana Săsăran
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.